Found 21 matching trials
Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma PHASE2 To estimate the antitumor activity of paclitaxel, carboplatin, plus BSI-201...
Show More Learn More & Join Trial
Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma PHASE1 The phase I portion of study is designed to determine the Maximum Tolerated...
Show More Learn More & Join Trial
Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors PHASE1 Primary Objective:
\- To determine a dose of SAR240550 to be further studi...
Show More Location
Sanofi-Aventis Investigational Site Number 392001
Learn More & Join Trial
Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients PHASE2 Primary Objective:
\- to assess the pathological Complete Response (pCR) r...
Show More Location
Investigational Site Number 250001
Learn More & Join Trial
Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PHASE2 The goal of this study was to determine the efficacy of iniparib (BSI-201/S...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid Tumors PHASE1 The purpose of this study is to assess the safety, establish the maximum to...
Show More Learn More & Join Trial
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors PHASE1 Primary Objective:
* To assess the safety and the maximum tolerated dose(M...
Show More Location
Investigational Site Number 840002
Learn More & Join Trial
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis PHASE2 The purpose of the study is to investigate the response rate for triple neg...
Show More Location
University of Alabama At Birmingham
Learn More & Join Trial
A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer PHASE2 The purpose of this study is to evaluate the effect of BSI-201 on the objec...
Show More Location
Massachusetts Ceneral Hospital
Learn More & Join Trial
A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer PHASE2 The purpose of this clinical trial was to determine whether combining inipa...
Show More Learn More & Join Trial